First drug-focused guideline outlines newer treatments for primary biliary cholangitis

For the archetypal time, a associated line from the American Gastroenterological Association (AGA) and American Association for the Study of Liver Diseases (AASLD) evaluates newer medications for superior biliary cholangitis (PBC), the astir communal cholestatic illness successful adults. Published successful Gastroenterology and HEPATOLOGY, the line provides evidence-based recommendations for diagnosis and treatment.